-
Science & technology
Science & technology
Novavax creates transformational vaccines that help address some of the world’s most pressing infectious diseases.
- Overview
- Our pipeline
- Matrix-M™ adjuvant
- Recombinant, protein-based nanoparticle vaccine
- Global vaccine approval/authorization map
COVID-19 UPDATESNovavax has demonstrated its ability to quickly produce viable vaccine candidates for emerging infectious diseases such as COVID-19.
-
Who we are
Who we are
We are a biotechnology company committed to help address serious infectious disease globally through the discovery, development, and delivery of innovative vaccines to patients around the world.
Build your future with usJoin other passionately curious people who are bringing innovative vaccines to the world
-
Insights
Insights
Novavax is committed to accelerating the development of new and promising vaccines by building on years of study and experience.
Our impact
As a global leader in vaccine development and research committed to improving global health, we know how important partnerships are to make vaccines make a difference.
Essential components of our commitment to public health include focused philanthropy and medical grants programs that support patient care and access, educate our next generation of health innovators, and champion health equity.
Continuing Medical Education Grants Program
The Novavax Continuing Medical Education Grants program supports funding for high-quality independent educational initiatives which serve to enhance the knowledge and skills of healthcare professionals, and are aligned with Novavax' areas of interest.
